Residency · Residency · Psychiatry

Autism Spectrum Disorder: Recognition and Support

Introduction

Autism spectrum disorder (ASD) is a neurodevelopmental condition defined by persistent deficits in social communication and interaction alongside restricted, repetitive patterns of behavior, interests, or activities. DSM-5 collapsed previous subtypes (autistic disorder, Asperger's disorder, PDD-NOS) into a single spectrum diagnosis with severity levels. Psychiatrists must recognize ASD across the lifespan, manage psychiatric comorbidities, and advocate for appropriate support.

Epidemiology

CDC prevalence estimate: approximately 1 in 36 children in the United States. Male-to-female ratio historically reported at 4:1, but increasingly recognized that females are underdiagnosed due to camouflaging or masking behaviors. No association with parental vaccination; this has been conclusively refuted.

DSM-5 Diagnostic Criteria

Domain A: Social Communication and Interaction Deficits

Deficits in social-emotional reciprocity (e.g., abnormal social approach, reduced sharing of interests, failure to initiate or respond to social interactions) Deficits in nonverbal communicative behaviors (e.g., poor eye contact, limited use of gestures, flat or incongruent facial expressions) Deficits in developing, maintaining, and understanding relationships.

Domain B: Restricted, Repetitive Behaviors

Stereotyped or repetitive motor movements, use of objects, or speech (echolalia, idiosyncratic phrases) Insistence on sameness, inflexible adherence to routines, ritualized patterns. Highly restricted, fixated interests that are abnormal in intensity or focus. Hyper- or hypo-reactivity to sensory input (e.g., indifference to pain, aversion to specific sounds or textures)

Severity Levels

LevelSupport RequiredSocial CommunicationRestricted/Repetitive Behaviors
Level 1Requiring supportDifficulty initiating social interactions; atypical responses; may appear to have decreased interestInflexibility causes significant interference; difficulty switching activities; organizational problems
Level 2Requiring substantial supportMarked deficits in verbal/nonverbal communication; limited initiation; reduced response to social overturesInflexibility, restricted behaviors obvious to casual observer; distress with change; frequent enough to be noticed
Level 3Requiring very substantial supportSevere deficits; very limited initiation; minimal response to social overturesExtreme difficulty with change; marked distress; great restriction in behaviors; frequent stereotypies

Level 1: Requiring support. Level 2: Requiring substantial support. Level 3: Requiring very substantial support.

Screening and Diagnosis

Early Signs (Infancy and Toddlerhood)

Reduced response to name by 12 months. Absent or reduced pointing, showing, or joint attention behaviors. Limited pretend play by 18 months. Language delays or regression.

Screening Tools

Modified Checklist for Autism in Toddlers, Revised (M-CHAT-R/F): recommended at 18 and 24 months. Social Communication Questionnaire (SCQ) for older children. Autism Spectrum Quotient (AQ) for adolescents and adults.

Diagnostic Assessment

Autism Diagnostic Observation Schedule, Second Edition (ADOS-2): gold-standard observational assessment. Autism Diagnostic Interview-Revised (ADI-R): structured parent interview. Comprehensive developmental history and cognitive testing. Rule out hearing impairment, language disorders, and intellectual disability.

Psychiatric Comorbidities

Anxiety disorders: present in 40-50% of individuals with ASD. ADHD: co-occurs in approximately 30-50% (DSM-5 now permits dual diagnosis) Depression: common in adolescents and adults, particularly those with average or above-average intelligence. Irritability and aggression: may reflect communication difficulties, sensory overload, or co-occurring conditions. Epilepsy: present in approximately 20-30%, more common with intellectual disability.

Intervention and Support

Behavioral Interventions

Applied Behavior Analysis (ABA): the most extensively studied intervention, particularly for young children. Early Start Denver Model (ESDM): naturalistic developmental behavioral intervention for children 12-48 months. Social skills groups for school-age children and adolescents.

Educational and Vocational Support

Individualized Education Programs (IEPs) or 504 plans. Structured environments with visual schedules and clear expectations. Supported employment programs for adults.

Pharmacotherapy

No medication treats core ASD symptoms. Risperidone and aripiprazole are FDA-approved for irritability associated with ASD in children. SSRIs may help with anxiety and repetitive behaviors (limited evidence in children) Stimulants and alpha-2 agonists for comorbid ADHD, though response rates are lower than in neurotypical children. Monitor carefully for paradoxical behavioral activation with SSRIs and stimulants.

Supporting Adults with ASD

Transition planning should begin in adolescence. Address independent living skills, vocational training, and social support networks. Screen for mental health conditions, which are often underdiagnosed and undertreated in this population.

Key Clinical Pearls

ASD in females often presents differently: better superficial social skills, more internalized symptoms, and intense interests that may appear more typical (e.g., animals, fiction) Autistic burnout in adults is characterized by chronic exhaustion, loss of function, and increased sensitivity, often triggered by sustained masking. Sensory accommodations (noise-canceling headphones, dimmed lighting, reduced waiting times) significantly improve clinical encounters. Always assess communication preferences; some individuals benefit from written questions, visual supports, or augmentative communication devices. Respect neurodiversity perspectives while providing evidence-based clinical care.

References

  1. Lord C, Brugha TS, Charman T, et al. Autism spectrum disorder. Nat Rev Dis Primers. 2020;6(1):5.
  2. Maenner MJ, Warren Z, Williams AR, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years. MMWR Surveill Summ. 2023;72(2):1-14.
  3. Lai MC, Lombardo MV, Baron-Cohen S. Autism. Lancet. 2014;383(9920):896-910.
  4. Hyman SL, Levy SE, Myers SM. Identification, evaluation, and management of children with autism spectrum disorder. Pediatrics. 2020;145(1):e20193447.

Read this lecture as Markdown